Logo image
Sign in
ENCORE: Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer (ENGOT-OV60/GOG-3052/RAMP 201): Dose intensity and subgroup analysis
Journal article   Peer reviewed

ENCORE: Avutometinib plus defactinib in recurrent low-grade serous ovarian cancer (ENGOT-OV60/GOG-3052/RAMP 201): Dose intensity and subgroup analysis

Rachel Grisham, Els Van Nieuwenhuysen, Carol Aghajanian, Veronique D’hondt, Bradley Monk, Andrew Clamp, Emily Prendergast, Ana Oaknin, Kari Ring, Silvia Derio, …
Gynecologic oncology, Vol.200, pp.34-35
09/2025

Metrics

3 Record Views

Details

Logo image